What Does Sex Have to Do With It? Implications for Pharmacotherapy
Monday April 08, 2019
Eastern Time (ET)
Room W206 A
Univ of South Carolina Sch of Med
Despite recognition of significant sex differences in susceptibility to stress related disorders such as drug abuse, depression and anxiety, the majority of animal models historically study only male populations. Moreover, the majority of preclinical and clinical studies are not designed to assess sex differences in therapeutic efficacy. Thus there is a lack of understanding of sex-biased mechanisms in the pathogenesis of these disorders, making strategies for sex specific pharmacotherapy unclear. This symposium focuses on studies involving sex differences in pharmacotherapy from clinical to preclinical models and spans layers of analysis from physiology to behavior.
- Pfizer Inc.
The Significance of Sex: Sex Differences in Drug Development
- University of California Davis
Sex Specific Effects of Oxytocin in the Bed Nucleus of the Stria Terminalis on Social Anxiety
- Univ of South Carolina Sch of Med
Sex Differences in Anti-inflammatory Therapies to Increase Resilience to Social Stress
- Wake Forest Sch of Med
Effects of Social Rank and Sex on Cocaine Self-Administration in Monkey Models of Drug Abuse